Literature DB >> 23837751

The rise and fall of cancer mortality in the USA: why does pancreatic cancer not follow the trend?

Jiemin Ma, Ahmedin Jemal.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23837751     DOI： 10.2217/fon.13.76

Source DB:  PubMed          Journal:  Future Oncol        ISSN： 1479-6694            Impact factor:   3.404


× No keyword cloud information.
  25 in total

1.  Next generation sequencing and functional pathway analysis to understand the mechanism of action of copper-tolfenamic acid against pancreatic cancer cells.

Authors:  Myrna Hurtado; Laszlo Prokai; Umesh T Sankpal; Blair Levesque; Rajasekhar Maram; Jaya Chhabra; Deondra T Brown; Raj K Gurung; Alvin A Holder; Jamboor K Vishwanatha; Riyaz Basha
Journal:  Process Biochem       Date:  2019-10-30       Impact factor: 3.757

2.  Dual Farnesyl and Geranylgeranyl Transferase Inhibitor Thwarts Mutant KRAS-Driven Patient-Derived Pancreatic Tumors.

Authors:  Aslamuzzaman Kazi; Shengyan Xiang; Hua Yang; Liwei Chen; Perry Kennedy; Muhammad Ayaz; Steven Fletcher; Christopher Cummings; Harshani R Lawrence; Francisca Beato; Ya'an Kang; Michael P Kim; Andrea Delitto; Patrick W Underwood; Jason B Fleming; Jose G Trevino; Andrew D Hamilton; Said M Sebti
Journal:  Clin Cancer Res       Date:  2019-06-21       Impact factor: 12.531

Review 3.  Pancreatic Cancer Screening.

Authors:  Koushik K Das; Dayna Early
Journal:  Curr Treat Options Gastroenterol       Date:  2017-12

4.  Overexpression of folate receptor alpha is an independent prognostic factor for outcomes of pancreatic cancer patients.

Authors:  Shizuma Omote; Katsuyoshi Takata; Takehiro Tanaka; Tomoko Miyata-Takata; Yoshiyuki Ayada; Mai Noujima-Harada; Rika Omote; Tetsuya Tabata; Yasuharu Sato; Tatsuya Toyokawa; Hironari Kato; Takahito Yagi; Hiroyuki Okada; Tadashi Yoshino
Journal:  Med Mol Morphol       Date:  2018-06-20       Impact factor: 2.309

5.  High Expression of Long Noncoding RNA HOTAIRM1 is Associated with the Proliferation and Migration in Pancreatic Ductal Adenocarcinoma.

Authors:  Yongyun Luo; Yaqin He; Xiaoping Ye; Jianjun Song; Qi Wang; Yukui Li; Xiaoliang Xie
Journal:  Pathol Oncol Res       Date:  2019-01-06       Impact factor: 3.201

6.  Target Deconvolution of a Multikinase Inhibitor with Antimetastatic Properties Identifies TAOK3 as a Key Contributor to a Cancer Stem Cell-Like Phenotype.

Authors:  Yansong Bian; Yaroslav Teper; Lesley A Mathews Griner; Taylor J Aiken; Vivek Shukla; Rajarshi Guha; Paul Shinn; Hong-Wu Xin; Holger Pflicke; Astin S Powers; Dandan Li; Jian-Kang Jiang; Paresma Patel; Steven A Rogers; Jeffrey Aubé; Marc Ferrer; Craig J Thomas; Udo Rudloff
Journal:  Mol Cancer Ther       Date:  2019-08-08       Impact factor: 6.261

7.  Pre-operative Plasma miR-21-5p Is a Sensitive Biomarker and Independent Prognostic Factor in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgical Resection.

Authors:  Petr Karasek; Natalia Gablo; Jan Hlavsa; Igor Kiss; Petra Vychytilova-Faltejskova; Marketa Hermanova; Zdenek Kala; Ondrej Slaby; Vladimir Prochazka
Journal:  Cancer Genomics Proteomics       Date:  2018 Jul-Aug       Impact factor: 4.069

8.  Metabolic imaging of pancreatic ductal adenocarcinoma detects altered choline metabolism.

Authors:  Marie-France Penet; Tariq Shah; Santosh Bharti; Balaji Krishnamachary; Dmitri Artemov; Yelena Mironchik; Flonné Wildes; Anirban Maitra; Zaver M Bhujwalla
Journal:  Clin Cancer Res       Date:  2014-11-04       Impact factor: 12.531

9.  PET/MRI in pancreatic and periampullary cancer: correlating diffusion-weighted imaging, MR spectroscopy and glucose metabolic activity with clinical stage and prognosis.

Authors:  Bang-Bin Chen; Yu-Wen Tien; Ming-Chu Chang; Mei-Fang Cheng; Yu-Ting Chang; Chih-Horng Wu; Xin-Jia Chen; Ting-Chun Kuo; Shih-Hung Yang; I-Lun Shih; Hong-Shiee Lai; Tiffany Ting-Fang Shih
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-03-19       Impact factor: 9.236

10.  Elevated DNA damage response in pancreatic cancer.

Authors:  Michael Osterman; Deion Kathawa; Diangang Liu; Huan Guo; Chao Zhang; Mo Li; Xiaochun Yu; Fei Li
Journal:  Histochem Cell Biol       Date:  2014-07-08       Impact factor: 4.304
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.